Results 111 to 120 of about 17,092 (277)

Bioorthogonal Janus microparticles for photothermal and chemo‐therapy

open access: yesSmart Medicine
Bioorthogonal chemistry, recognized as a highly efficient tool in chemical biology, has shown significant value in cancer treatment. The primary objective is to develop efficient delivery strategies to achieve enhanced bioorthogonal drug treatment for ...
Qingfei Zhang   +4 more
doaj   +1 more source

Senolysis Enabled by Senescent Cell-Sensitive Bioorthogonal Tetrazine Ligation

open access: yesAngewandte Chemie
Although clearance of senescent cells has been proved to slow down aging process and promote anti-cancer chemotherapy, the development of senolytics remains challenging.
Meng-Yang Chang   +6 more
semanticscholar   +1 more source

Synthesis of NAD analogs to develop bioorthogonal redox system

open access: yes, 2013
Three new nicotinamide adenine dinucleotide (NAD) analogs were synthesized, and their characteristics as cofactors for Escherichia coli malic enzyme (ME) and its double mutant ME L310R/Q401C were analyzed.
Hou ShuHua   +6 more
core   +1 more source

Prodrug activation by 4,4’-bipyridine-mediated aromatic nitro reduction

open access: yesNature Communications
Unleashing prodrugs through nitro-reduction is a promising strategy in cancer treatment. In this study, we present a unique bioorthogonal reaction for aromatic nitro reduction, mediated by 4,4‘-bipyridine. The reaction is a rare example of organocatalyst-
Qing Wang   +5 more
doaj   +1 more source

Activation of Metal Complexes With Ultrasound Waves for Targeted Anticancer Therapy

open access: yesAngewandte Chemie International Edition, EarlyView.
Ultrasound enables non‐invasive activation of metal‐based therapeutics deep within tumors. Acoustic cavitation can drive sonodynamic reactive oxygen species generation or mechanochemical metal–ligand bond dissociation, enabling controlled release of bioactive payloads.
Félix Grosjean   +3 more
wiley   +1 more source

1,2,4-Triazines Are Versatile Bioorthogonal Reagents

open access: yes, 2016
A new class of bioorthogonal reagents, 1,2,4-triazines, is described. These scaffolds are stable in biological media and capable of robust reactivity with trans-cyclooctene (TCO).
Ryan A. Mehl (1313565)   +6 more
core   +1 more source

Inorganic nanoparticles as scaffolds for bioorthogonal catalysts

open access: yes, 2023
Bioorthogonal transition metal catalysts (TMCs) transform therapeutically inactive molecules (pro-drugs) into active drug compounds. Inorganic nanoscaffolds protect and solubilize catalysts while offering a flexible design space for decoration with ...
Vincent M. Rotello   +5 more
core   +1 more source

Bioorthogonal masked acylating agents for proximity-dependent RNA labelling

open access: yesNature Chemistry
RNA localization is highly regulated, with subcellular organization driving context-dependent cell physiology. Although proximity-based labelling technologies that use highly reactive radicals or carbenes provide a powerful method for unbiased mapping of
Shubhashree Pani   +4 more
semanticscholar   +1 more source

Bioorthogonal Activation of Deep Red Photoredox Catalysis Inducing Pyroptosis

open access: yesJournal of the American Chemical Society
The revolutionary impact of photoredox catalytic processes has ignited novel avenues for exploration, empowering us to delve into nature in unprecedented ways and to pioneer innovative biotechnologies for therapy and diagnosis.
Jungryun Kim   +7 more
semanticscholar   +1 more source

Synthesis of a Stable Hydrophilic trans‐Cyclooctene Amino Acid Unlocks Fast Bioorthogonal Click Chemistry for the Generation of Antibody‐Drug Conjugates by Genetic Code Expansion

open access: yesAngewandte Chemie International Edition, EarlyView.
A novel trans‐cyclooctene (TCO) based noncanonical amino acid (ncAA) is reported, characterized by high hydrophilicity and remarkable stability to trans‐cis isomerization. Its incorporation via genetic code expansion into an antibody and subsequent conjugation resulted in a highly efficacious antibody‐drug conjugate (ADC).
Georgi R. Genov   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy